← Back to Screener
Bionano Genomics, Inc. Common Stock (BNGO)
Price$1.17
Value ScoreA
Growth ScoreC
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-44.68%
Price vs S&P 500 (4W)-9.29%
VGM Score60.06
Market Capitalization$13.43M
All Metrics
Book Value / Share (Quarterly)$3.32
P/TBV (Annual)0.39x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)0.84%
Cash Flow / Share (Quarterly)$-1.71
Price vs S&P 500 (YTD)-31.69%
Gross Margin (TTM)46.97%
Net Profit Margin (TTM)-109.96%
EPS (TTM)$-5.11
10-Day Avg Trading Volume0.18M
EPS Excl Extra (TTM)$-5.11
Revenue Growth (5Y)27.38%
EPS (Annual)$-4.85
ROI (Annual)-54.81%
Gross Margin (Annual)46.25%
Net Profit Margin (5Y Avg)-396.04%
Cash / Share (Quarterly)$1.28
Revenue Growth QoQ (YoY)3.56%
ROA (Last FY)-35.87%
Revenue Growth TTM (YoY)0.96%
EBITD / Share (TTM)$-3.08
ROE (5Y Avg)-138.50%
Operating Margin (TTM)-114.03%
Cash Flow / Share (Annual)$-1.52
P/B Ratio0.36x
P/B Ratio (Quarterly)0.35x
Net Income / Employee (Annual)$-277,800
EV / Revenue (TTM)0.48x
Net Interest Coverage (TTM)-127.56x
ROA (TTM)-43.07%
EPS Incl Extra (Annual)$-4.85
Current Ratio (Annual)1.98x
Quick Ratio (Quarterly)1.36x
3-Month Avg Trading Volume0.28M
52-Week Price Return-68.21%
Revenue / Employee (TTM)$302,500
Tangible BV / Share (Quarterly)$3.06
P/S Ratio (Annual)0.47x
Asset Turnover (Annual)0.39x
52-Week High$5.50
Operating Margin (5Y Avg)-391.00%
EPS Excl Extra (Annual)$-4.85
CapEx CAGR (5Y)11.41%
Tangible BV CAGR (5Y)3.59%
26-Week Price Return-36.76%
Quick Ratio (Annual)1.59x
13-Week Price Return3.54%
Total Debt / Equity (Annual)0.08x
Current Ratio (Quarterly)1.84x
Enterprise Value$13.71M
Revenue / Share Growth (5Y)45.06%
Asset Turnover (TTM)0.39x
Book Value / Share Growth (5Y)17.49%
Revenue / Employee (Annual)$300,100
Inventory Turnover (Annual)1.85x
Pretax Margin (Annual)-92.35%
Cash / Share (Annual)$1.79
3-Month Return Std Dev77.63%
Gross Margin (5Y Avg)23.38%
Net Income / Employee (TTM)$-332,600
ROE (Last FY)-59.42%
Net Interest Coverage (Annual)-10.84x
EPS Basic Excl Extra (Annual)$-4.85
Receivables Turnover (TTM)7.68x
Total Debt / Equity (Quarterly)0.10x
EPS Incl Extra (TTM)$-5.11
Receivables Turnover (Annual)5.73x
ROI (TTM)-65.95%
P/S Ratio (TTM)0.47x
Pretax Margin (5Y Avg)-400.92%
Revenue / Share (Annual)$5.24
Tangible BV / Share (Annual)$3.73
Price vs S&P 500 (52W)-92.57%
Year-to-Date Return-23.53%
5-Day Price Return-6.40%
EPS Normalized (Annual)$-4.85
ROA (5Y Avg)-70.55%
Net Profit Margin (Annual)-92.59%
Month-to-Date Return-5.65%
Cash Flow / Share (TTM)$-6.78
EBITD / Share (Annual)$-5.13
Operating Margin (Annual)-116.95%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-129.36%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-5.11
P/TBV (Quarterly)0.38x
P/B Ratio (Annual)0.35x
Inventory Turnover (TTM)2.05x
Pretax Margin (TTM)-109.72%
Book Value / Share (Annual)$4.14
Price vs S&P 500 (13W)-4.71%
Beta1.64x
Revenue / Share (TTM)$2.62
ROE (TTM)-71.54%
52-Week Low$1.06
vGradeA
gGradeC
mGradeD
vgmGradeB
Show chart for
Earnings Surprise History
Q1 26-0.76est. -0.90
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
4.00
4.00
4.00
4.00
Industry Peers — Lab Analytical Instruments(24)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
BNGOBionano Genomics, Inc. Common Stock | A | C | D | $1.17 |
| AAgilent Technologies Inc. | C | C | B | $135.44 |
| WATWaters Corp | D | C | C | $365.36 |
| ILMNIllumina Inc | D | D | B | $162.32 |
| MTDMettler-Toledo International | D | C | C | $1154.33 |
| RVTYRevvity, Inc. | C | D | C | $98.37 |
| BRKRBruker Corporation | D | D | B | $56.39 |
| BIOBio-Rad Laboratories, Inc.Class A | C | F | B | $294.32 |
| BIO.BBio-Rad Laboratories, Inc. Class B | C | F | B | $304.15 |
| AVTRAvantor, Inc. | B | D | C | $9.16 |
| TXG10x Genomics, Inc. Class A Common Stock | D | C | A | $31.04 |
About
Bionano Genomics develops optical genome mapping systems for detecting structural variations, enabling the discovery of new diagnostics and therapeutic targets in pharmaceutical and clinical research. The company generates revenue from its Saphyr platform, instruments, and consumables, with EMEA as its largest geographic market and operations spanning the Americas, EMEA, and Asia Pacific.